|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 118.00 AUD | -0.84% |
|
-4.22% | -54.73% |
| 13/07 | Cochlear Limited Announces FDA Clearance of The Osia 3 Sound Processor | CI |
| 25/06 | From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis | RE |
Company Valuation: Cochlear Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,546 | 13,070 | 15,043 | 21,754 | 19,647 | 7,782 | - | - |
| Change | - | -21.01% | 15.1% | 44.62% | -9.69% | -60.39% | - | - |
| Enterprise Value (EV) 1 | 15,981 | 12,440 | 14,689 | 21,240 | 19,371 | 7,597 | 7,538 | 7,476 |
| Change | - | -22.16% | 18.08% | 44.6% | -8.8% | -60.78% | -0.78% | -0.83% |
| P/E | 50.7x | 45.2x | 50.1x | 61x | 50.7x | 32.5x | 23.9x | 21x |
| PBR | 9.72x | 7.75x | 8.63x | 11.9x | 10.1x | 4.08x | 3.9x | 3.68x |
| PEG | - | -3.9x | 12.65x | 3.2x | 5.72x | -0.9x | 0.7x | 1.5x |
| Capitalization / Revenue | 11.1x | 7.93x | 7.69x | 9.63x | 8.38x | 3.35x | 3.23x | 3.04x |
| EV / Revenue | 10.7x | 7.55x | 7.51x | 9.41x | 8.27x | 3.27x | 3.13x | 2.92x |
| EV / EBITDA | 39x | 27.3x | 30.8x | 36x | 31.7x | 15.4x | 13.6x | 12.3x |
| EV / EBIT | 48.4x | 32.5x | 37.1x | 42.1x | 37.2x | 19.3x | 16.7x | 14.9x |
| EV / FCF | 69.5x | 37.5x | 47x | 65.1x | 143x | 32x | 23.3x | 20.8x |
| FCF Yield | 1.44% | 2.67% | 2.13% | 1.54% | 0.7% | 3.12% | 4.29% | 4.82% |
| Dividend per Share 2 | 2.55 | 3 | 3.3 | 4.1 | 4.3 | 3.414 | 3.695 | 4.053 |
| Rate of return | 1.01% | 1.51% | 1.44% | 1.23% | 1.43% | 2.87% | 3.1% | 3.41% |
| EPS 2 | 4.967 | 4.396 | 4.57 | 5.445 | 5.928 | 3.667 | 4.98 | 5.678 |
| Distribution rate | 51.3% | 68.2% | 72.2% | 75.3% | 72.5% | 93.1% | 74.2% | 71.4% |
| Net sales 1 | 1,493 | 1,648 | 1,956 | 2,258 | 2,343 | 2,321 | 2,410 | 2,560 |
| EBITDA 1 | 409.7 | 455.7 | 477 | 589.7 | 611.7 | 492.1 | 553.6 | 607.8 |
| EBIT 1 | 330.2 | 382.7 | 396.1 | 504.8 | 521.3 | 393.7 | 451.9 | 501.8 |
| Net income 1 | 326.5 | 289.1 | 300.6 | 356.8 | 388.9 | 236.8 | 322.2 | 374.3 |
| Net Debt 1 | -564.6 | -629.3 | -353.7 | -513.6 | -275.7 | -185 | -244.6 | -306.8 |
| Reference price 2 | 251.67 | 198.70 | 229.07 | 332.15 | 300.42 | 119.00 | 119.00 | 119.00 |
| Nbr of stocks (in thousands) | 65,744 | 65,775 | 65,668 | 65,494 | 65,397 | 65,399 | - | - |
| Announcement Date | 19/8/21 | 18/8/22 | 14/8/23 | 14/8/24 | 14/8/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.45x | 3.27x | 15.44x | 2.87% | 5.45B | ||
| 32.58x | 5.66x | 18.39x | 1.07% | 19.52B | ||
| 20.44x | 3.38x | 12.31x | 2.29% | 15.05B | ||
| 20.18x | 2.59x | 10.04x | 1.85% | 4.23B | ||
| 18.59x | 2.08x | 10.21x | -.--% | 1.71B | ||
| 54.81x | 3.38x | 26.94x | 0.84% | 1.7B | ||
| 20.88x | 4.21x | 12.63x | 0.95% | 1.19B | ||
| -22.17x | - | - | - | 435M | ||
| Average | 22.22x | 3.51x | 15.14x | 1.41% | 6.16B | |
| Weighted average by Cap. | 27.31x | 4.19x | 15.34x | 1.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- COH Stock
- Valuation Cochlear Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















